Medivation, Inc. (NASDAQ:MDVN)
CAPS Rating:
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.
Growing the love for investing
A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Got caught on the wrong side of this one because I under-estimated its potential